BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23150445)

  • 1. Generation of p53-deficient induced pluripotent stem cells from mouse embryo fibroblasts.
    Alexandrova EM; Moll UM
    Methods Mol Biol; 2013; 962():157-64. PubMed ID: 23150445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
    Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging methods for preparing iPS cells.
    Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
    Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-step generation of induced pluripotent stem cells from mouse fibroblasts using Id3 and Oct4.
    Moon JH; Heo JS; Kwon S; Kim J; Hwang J; Kang PJ; Kim A; Kim HO; Whang KY; Yoon BS; You S
    J Mol Cell Biol; 2012 Feb; 4(1):59-62. PubMed ID: 22131360
    [No Abstract]   [Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
    Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
    Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
    Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
    Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
    Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
    Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem (iPS) cell research overview.
    Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells.
    Zaehres H; Kim JB; Schöler HR
    Methods Enzymol; 2010; 476():309-25. PubMed ID: 20691874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
    Desponts C; Ding S
    Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
    Heffernan C; Sumer H; Verma PJ
    J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landmark approach to generating human stem cells.
    Daubman S
    Circ Res; 2011 Jan; 108(2):161-3. PubMed ID: 21252149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.